Relation

Nanomaterial-based Drug Delivery Systems for SARS-CoV-2

Nanomaterials could be used to deliver drugs to the pulmonary system via inhalators. Cellular binding of viral particles at the alveoli can be inhibited using targeted nanoparticles (NPs) against angiotensin-converting enzyme 2 (ACE2) receptors or viral S protein.

0

1

Updated 2020-07-31

Contributors are:

Who are from:

Tags

SARS-CoV-2 (COVID-19)

Biomedical Sciences